Pulmonary arterial sarcoma: A case report
Yin Wang,Chunyan Rong,Jingwei Liu,Xuhan Liu,Weihua Zhang
DOI: https://doi.org/10.1097/md.0000000000037194
IF: 1.6
2024-02-25
Medicine
Abstract:Pulmonary artery sarcoma (PAS) is a sporadic malignant mesenchymal tumor originating from the pulmonary arteries, the etiology and pathogenesis are still unclear, with a reported incidence of 0.001% to 0.030% [ 1 , 2 ] Mandelstamm first discovered and reported PAS by autopsy in 1923, and now there are less than 450 cases reported in the domestic and international literature. [ 1 , 3–5 ] Clinical manifestations and imaging examinations of PAS lack specificity, often manifested as dyspnea, chest pain, cough, hemoptysis, syncope and other symptoms, and easily misdiagnosed as pulmonary embolism (PE) and pulmonary hypertension [ 3 , 4 ] and pathological biopsy is the gold standard for the confirmation of the diagnosis of PAS. [ 6 , 7 ] PAS is characterized by high metastasis, high mortality, and high misdiagnosis, [ 2 ] and treatment can be divided into surgery, chemotherapy, radiotherapy, and immunotherapy, with surgery being the mainstay. It has been reported in the literature that the 1-year and 2-year survival rates after surgery are 22% and 7%, respectively. [ 6 , 7 ] In this paper, we report a case of PAS misdiagnosed as PE admitted to the First Hospital of Jilin University and review the related literature.
medicine, general & internal